|
YY1AP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.599890E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.563260E-03 |
| Normal-vs-Stage2 |
4.393000E-01 |
| Normal-vs-Stage3 |
4.535600E-01 |
| Normal-vs-Stage4 |
4.646200E-01 |
| Stage1-vs-Stage2 |
2.846600E-01 |
| Stage1-vs-Stage3 |
5.015700E-02 |
| Stage1-vs-Stage4 |
8.909600E-02 |
| Stage2-vs-Stage3 |
7.636000E-01 |
| Stage2-vs-Stage4 |
8.019400E-01 |
| Stage3-vs-Stage4 |
9.774400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.725800E-02 |
| Normal-vs-AfricanAmerican |
4.412000E-01 |
| Normal-vs-Asian |
1.063560E-02 |
| Caucasian-vs-AfricanAmerican |
5.195400E-01 |
| Caucasian-vs-Asian |
2.976400E-01 |
| AfricanAmerican-vs-Asian |
1.726770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.224600E-01 |
| Normal-vs-Female |
2.390400E-04 |
| Male-vs-Female |
4.656100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.183800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.676310E-02 |
| Normal-vs-Age(61-80Yrs) |
6.015700E-02 |
| Normal-vs-Age(81-100Yrs) |
4.624800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.446000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.332200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.394200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.520000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.861600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.213600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.14380000044201E-07 |
| Normal-vs-Grade 2 |
8.438800E-04 |
| Normal-vs-Grade 3 |
2.224000E-01 |
| Normal-vs-Grade 4 |
9.739000E-01 |
| Grade 1-vs-Grade 2 |
3.011900E-02 |
| Grade 1-vs-Grade 3 |
5.636300E-03 |
| Grade 1-vs-Grade 4 |
2.609200E-04 |
| Grade 2-vs-Grade 3 |
4.000500E-02 |
| Grade 2-vs-Grade 4 |
1.044320E-02 |
| Grade 3-vs-Grade 4 |
2.989000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.29640000015685E-07 |
| Normal-vs-ccB subtype |
6.541000E-01 |
| ccA subtype-vs-ccB subtype |
8.70559999643916E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.437630E-02 |
| Normal-vs-N1 |
6.991600E-02 |
| N0-vs-N1 |
8.094000E-01 |
|
|
